Animas picks up glucose sensing tech as Cygnus folds
This article was originally published in Clinica
Executive Summary
West Chester, Pennsylvania-based insulin infusion pump maker Animas has signed a deal with Cygnus, the Redwood City, California-based glucose sensing technology firm, to acquire the latter's technology. Cygnus is also seeking shareholder approval to dissolve the company, although it says this is not dependent on the sale of its assets to Animas.